$XERS I think shorts are gambling on an Earnings miss. Zacks reported an article suggesting that they might miss the Earnings, or might not.. anyways Earnings should not be bad seeing as scripts grew very fast. They hired a lot of people so might have an increase in costs but Revenue should outweigh it. nasdaq.com/articles/xeris-p...
Xeris Pharmaceuticals (XERS) May Report Negative Earnings: Know the Trend Ahead of Q1 Releasevia: Nasdaq